Asensus Surgical Inc (ASXC)

[doomdevice]

Study showing significantly lower instrument costs than da Vinci with comparable learning curve and console times.

https://www.linkedin.com/posts/asensus-surgical-inc_digitallaparoscopy-senhance-roboticsurgery-activity-6790679507914252288-3j9t

In this real-world comparative assessment from four U.S. and European hospitals, results showed that the learning curve of gynecological Senhance®? surgeons compared to those of da Vinci gynecological surgeons achieved lower median instrument costs with comparable console times. Case costs between Senhance and laparoscopic-assisted vaginal hysterectomy cases were comparable as well. This further supports how Digital Laparoscopy with Senhance is reducing the economic limitations of current robotic systems so that the benefits of our technology can reach more patients.

Learn more about the assessment here:
https://pubmed.ncbi.nlm.nih.gov/33860631/